The Latest Cardiac and Vascular News
SAN FRANCISCO–(BUSINESS WIRE)–Element Science, an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients, announced that it has received the European Union’s CE mark certification and Great Britain’s UK Conformity Assessed (UKCA) marking for its novel Patch Wearable Cardioverter Defibrillator (P-WCD) from its Notified Body, the […]
WEST CHESTER, Pa., Jan. 26, 2024 /PRNewswire/ — VESTECK, Inc. is excited to announce that the “SUTURE-TIGHT”tm catheter technology was presented at the iconic ISET meeting in Miami FL on January 24, 2024. During the main stage sessions, Sean Lyden MD, Professor and Chairman Vascular…
BRAINTREE, Mass., Jan. 26, 2024 /PRNewswire/ — PrepMD, the leading cardiac healthcare solutions provider, announced today the accreditation of their online healthcare training programs for Nursing Continuing Education Units (CEUs). Achieved in collaboration with Gladwell CME, a pioneer…
FORT LAUDERDALE, Fla., Jan. 26, 2024 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that it has filed a pre-submission application with the U.S. […]
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced new data at CMR 2024 demonstrating favorable effects on cardiac structure, function and fibrosis related to treatment with aficamten in FOREST-HCM (Follow-up, Open-Label, Research Evaluation of Sustained Treatment with Aficamten in HCM), the open label extension clinical trial of aficamten in patients with hypertrophic cardiomyopathy (HCM). In many patients with […]
SCOTTSDALE, Ariz., Jan. 25, 2024 (GLOBE NEWSWIRE) — Confluent Medical Technologies (Confluent) announced that it has partnered with ATI to invest more than $50 million over the next several years in ATI’s Nitinol melt and materials conversion infrastructure. With this significant investment, which will more than triple ATI’s melt capacity […]
DUBLIN–(BUSINESS WIRE)–CroíValve, an Irish-U.S. based medical device company with a novel, transcatheter solution for tricuspid regurgitation (TR), today announced initiation of its Early Feasibility Study (EFS) for the DUO™ Tricuspid Coaptation Valve System, following FDA IDE and CMS approval. The TANDEM II trial is a prospective, multi-center, non-randomized single-arm study […]
DARIEN, Conn. & BURLINGTON, Mass.–(BUSINESS WIRE)–The Vascular Care Group (“TVCG”) and Mangrove Management Partners (“Mangrove”, the affiliated management company of TVCG), announced today that Dr. Paul Gagne, will assume an expanded leadership role as Chief of Clinical Operations and Research. In this capacity, Dr. Paul Gagne will further lead and […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional treatment of vascular disease, is pleased to announce that Art Taylor has been appointed to the Endologix Board of Directors. “Art’s wide-ranging experience in the healthcare sector adds a remarkable depth […]
CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal Ramjee, MD FACC CCMS, as a Strategic Advisor. Dr. Ramjee is a cardiologist and a health innovation leader, serving as the National Co-Chair of Cardiology and Innovation at CommonSpirit Health Enterprise and […]
